Secure your place at the Digiday Publishing Summit in Vail, March 23-25
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Why Edward Jones’ agentic AI trial comes with limits
Edward Jones tests agentic AI to drive marketing productivity, taking a measured approach as it stops short of full automation.
Footwear brands navigate uncertainty after latest tariffs flip-flop
Some 99% of footwear sold in the U.S. today is imported, according to the Footwear Distributors and Retailers of America.
Brands at eTail Palm Springs share lessons on the ‘messy middle’ of building AI tools
Here’s a rundown of lessons brands have shared about their AI implementations so far.